Patents by Inventor Gerard Bourke

Gerard Bourke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11554379
    Abstract: A flotation line for treating mineral ore particles suspended in slurry, including at least three flotation units arranged in fluid connection with each other for allowing gravity-driven slurry flow between flotation units, and a feed inlet for supplying slurry into a first flotation unit; wherein at least three flotation units are configured to be uniplanar, each flotation unit includes at least one flotation cell; and wherein the launder lip height of each uniplanar flotation unit is lower than the launder lip height of the preceding uniplanar flotation unit in the direction of the slurry flow, so that an angle of sloping between a first uniplanar flotation cell, equipped with a launder lip and being larger than 150 m3, and a last uniplanar flotation cell, equipped with a launder lip and being larger than 40 m3, is formed; and the angle is 1.5 to 10 degrees relative to horizontal.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: January 17, 2023
    Assignee: OUTOTEC (FINLAND) OY
    Inventors: Peter Gerard Bourke, Antti Rinne, Rob Coleman
  • Patent number: 11247213
    Abstract: A flotation method for recovering valuable metal containing ore particles from ore particles suspended in slurry is disclosed. In the method, the slurry is treated in an at least one overflow flotation cell and the valuable metal containing ore particles are recovered by conducting the continuous upwards flow of slurry out of the at least one overflow flotation cell as slurry overflow. At least part of the slurry overflow is conducted to a further treatment step in a treatment system.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: February 15, 2022
    Assignee: OUTOTEC (FINLAND) OY
    Inventors: Antti Rinne, Peter Gerard Bourke
  • Patent number: 10569196
    Abstract: Provided are a method and apparatus for treating a feed stream for a flotation device comprising a mechanical agitator in a tank, the feed stream comprising solid particles. The method comprises generating microbubbles in a diluation water stream, mixing the diluation water stream with the feed stream to facilitate attachment of the microbubbles to the solid particles in the feed stream and generate bubbles for attachment to microbubble-attached solid particles, and fluidly connecting the feed stream to the flotation device. The apparatus comprises a feed stream conduit fluidly connected to the flotation device, a diluation water stream conduit fluidly connected to the feed stream conduit for conveying the diluation water stream to the feed stream, and a microbubble generator connected to the diluation water stream conduit for generating microbubbles in the fluid stream.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: February 25, 2020
    Assignee: OUTOTEC (FINLAND) OY
    Inventor: Peter Gerard Bourke
  • Publication number: 20190176166
    Abstract: A flotation method for recovering valuable metal containing ore particles from ore particles suspended in slurry is disclosed. In the method, the slurry is treated in an at least one overflow flotation cell and the valuable metal containing ore particles are recovered by conducting the continuous upwards flow of slurry out of the at least one overflow flotation cell as slurry overflow. At least part of the slurry overflow is conducted to a further treatment step in a treatment system.
    Type: Application
    Filed: August 15, 2016
    Publication date: June 13, 2019
    Inventors: Antti RINNE, Peter Gerard BOURKE
  • Publication number: 20190160476
    Abstract: A flotation line for treating mineral ore particles suspended in slurry, including at least three flotation units arranged in fluid connection with each other for allowing gravity-driven slurry flow between flotation units, and a feed inlet for supplying slurry into a first flotation unit; wherein at least three flotation units are configured to be uniplanar, each flotation unit includes at least one flotation cell; and wherein the launder lip height of each uniplanar flotation unit is lower than the launder lip height of the preceding uniplanar flotation unit in the direction of the slurry flow, so that an angle of sloping between a first uniplanar flotation cell, equipped with a launder lip and being larger than 150 m3, and a last uniplanar flotation cell, equipped with a launder lip and being larger than 40 m3, is formed; and the angle is 1.5 to 10 degrees relative to horizontal.
    Type: Application
    Filed: July 28, 2017
    Publication date: May 30, 2019
    Inventors: Peter Gerard BOURKE, Antti RINNE, Rob COLEMAN
  • Publication number: 20160214036
    Abstract: Provided are a method and apparatus for treating a feed stream for a flotation device comprising a mechanical agitator in a tank, the feed stream comprising solid particles. The method comprises generating microbubbles in a diluation water stream, mixing the diluation water stream with the feed stream to facilitate attachment of the microbubbles to the solid particles in the feed stream and generate bubbles for attachment to microbubble-attached solid particles, and fluidly connecting the feed stream to the flotation device. The apparatus comprises a feed stream conduit fluidly connected to the flotation device, a diluation water stream conduit fluidly connected to the feed stream conduit for conveying the diluation water stream to the feed stream, and a microbubble generator connected to the diluation water stream conduit for generating microbubbles in the fluid stream.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 28, 2016
    Applicant: OUTOTEC (FINLAND) OY
    Inventor: Peter Gerard BOURKE
  • Patent number: 9040549
    Abstract: The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases.
    Type: Grant
    Filed: April 11, 2013
    Date of Patent: May 26, 2015
    Assignee: YM Biosciences Australia Pty Ltd.
    Inventors: David Gerard Bourke, Xianyong Bu, Christopher John Burns, Anthony Nicholas Cuzzupe, John Thomas Feutrill, Tracy Leah Nero, Beata Maria Blannin, Jun Zeng, Shaun Patrick Gaynor
  • Patent number: 8846704
    Abstract: The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: September 30, 2014
    Assignee: YM Biosciences Austraila Pty Ltd
    Inventors: David Gerard Bourke, Xianyong Bu, Christopher John Burns, Anthony Nicholas Cuzzupe, John Thomas Feutrill, Tracy Leah Nero, Beata Maria Blannin, Jun Zeng, Shaun Patrick Gaynor
  • Patent number: 8765755
    Abstract: The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.
    Type: Grant
    Filed: December 5, 2012
    Date of Patent: July 1, 2014
    Assignee: YM Biosciences Australia Pty Ltd.
    Inventors: David Gerard Bourke, Christopher John Burns, Anthony Nicholas Cuzzupe, John Thomas Feutrill, Marcel Robert Kling, Tracy Leah Nero
  • Publication number: 20140051703
    Abstract: The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases.
    Type: Application
    Filed: April 11, 2013
    Publication date: February 20, 2014
    Applicant: Cytopia Research Pty Ltd.
    Inventors: David Gerard BOURKE, Xianyong Bu, Christopher John Burns, Anthony Nicholas Cuzzupe, John Thomas Feutrill, Tracy Leah Nero, Beata Maria Blannin, Jun Zeng, Shaun Patrick Gaynor
  • Publication number: 20140045848
    Abstract: The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases.
    Type: Application
    Filed: April 11, 2013
    Publication date: February 13, 2014
    Applicant: Cytopia Research Pty Ltd.
    Inventors: David Gerard Bourke, Xianyong Bu, Christopher John Burns, Anthony Nicholas Cuzzupe, John Thomas Feutrill, Tracy Leah Nero, Beata Maria Blannin, Jun Zeng, Shaun Patrick Gaynor
  • Patent number: 8354408
    Abstract: The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: January 15, 2013
    Assignee: YM Biosciences Australia Pty Ltd
    Inventors: David Gerard Bourke, Christopher John Burns, Anthony Nicholas Cuzzupe, John Thomas Feutrill, Marcel Robert Kling, Tracy Leah Nero
  • Patent number: 8021367
    Abstract: Methods and apparatus for repair of toe deformities using a bioabsorbable pin. The apparatus is a kit of part comprising a bioabsorbable pin, a predrill, a bone tamp, a cutter and a forceps. One surgical method of repairing toe deformities includes resecting a proximal interphalangeal joint, drilling a hole in a proximal phalanx using a proximal portion of a pin, removing the pin from the proximal phalanx, drilling a tip of a toe through middle and distal phalanxes, driving the pin retrograde and traversing the distal, middle and proximal phalanxes until the pin stops advancing due to resistance at a proximal cortex, holding the pin and powering a pin driver to separate a distal portion of the pin, and suturing the wound.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: September 20, 2011
    Assignee: Arthrex, Inc.
    Inventors: Gerard Bourke, Mihaela Morar, Peter A. Denove
  • Publication number: 20110092499
    Abstract: The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.
    Type: Application
    Filed: November 14, 2008
    Publication date: April 21, 2011
    Applicant: YM BIOSCIENCES AUSTRALIA PTY LTD
    Inventors: David Gerard Bourke, Christopher John Burns, Antony Nicholas Cuzzupe, John Thomas Feutrill, Marcel Robert Kling, Tracy Leah Nero
  • Patent number: 7886912
    Abstract: The invention provides an agitator (1) is disposed to agitate slurry within a flotation tank (2). The agitator includes a rotor (6) mounted on one end of a centrally disposed drive shaft (7) extending axially downwardly into the tank and driven by a motor (8) and associated gearbox (not shown). The other end of the drive shaft includes a mounting flange (9) adapted for connection to the motor. A stator (10) is also provided around the rotor. A froth deflection cone (11) extends around the drive shaft adjacent the top of the tank. The deflection cone is oriented such that its smallest diameter is located at its lower-most end nearest the rotor (6). An auxiliary agitator (12) is connected to the drive shaft at a position substantially midway between the underside of the deflection cone (11) and the top of the rotor (6), as shown in FIG. 1 and FIG. 2. The auxiliary agitator (12) includes agitation blades (13) extending radially outwardly from diametrically opposite sides of the shaft (7).
    Type: Grant
    Filed: March 16, 2004
    Date of Patent: February 15, 2011
    Assignee: Outotec Oyj
    Inventor: Peter Gerard Bourke
  • Publication number: 20100239631
    Abstract: The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases.
    Type: Application
    Filed: January 31, 2008
    Publication date: September 23, 2010
    Inventors: David Gerard Bourke, Xianyong Bu, Christopher John Burns, Anthony Nicholas Cuzzupe, John Thomas Feutrill, Tracy Leah Nero, Beata Maria Blannin, Jun Zeng, Shaun Patrick Gaynor
  • Patent number: 7624877
    Abstract: The invention provides a flotation device including a series of flotation tanks (1) for processing a slurry incorporating valuable minerals for extraction. At least one of the tanks includes a side outlet (15) adapted for the withdrawal of targeted relatively fine coarse particles from the slurry. The tanks also include a bottom outlet (14) for the withdrawal of relatively dense or coarse components of the slurry. The incorporation of bottom and side outlets allows the slurry to be separated into two parallel streams, one configured for optimal recovery of the relatively coarse or dense slurry components and the other for optimal recovery of the relatively fine slurry components. In this way, outflow slurry from downstream tanks in the coarse particle stream has a higher proportion of coarser particles than was present in the inflow slurry from the upstream tanks.
    Type: Grant
    Filed: March 16, 2004
    Date of Patent: December 1, 2009
    Assignee: Outotec Oyj
    Inventor: Peter Gerard Bourke
  • Publication number: 20090170926
    Abstract: The present invention provides a method of treatment or prophylaxis of hepatitis B virus in a subject comprising administering an effective amount of a compound of formula (1) or a pharmaceutically acceptable derivative, salt or prodrug thereof. In addition, there is provided compounds of formula (1) and pharmaceutical compositions thereof. Further, methods of preparing compounds of formula (1) are disclosed.
    Type: Application
    Filed: March 31, 2005
    Publication date: July 2, 2009
    Applicant: Monash Univeristy
    Inventors: Jonathan Alan Victor Coates, Eric Dale Jones, Susan Cox, Ian Crosby, David Gerard Bourke, Tyrone Pieter Jeynes
  • Publication number: 20080086139
    Abstract: Methods and apparatus for repair of toe deformities using a bioabsorbable pin. The apparatus is a kit of part comprising a bioabsorbable pin, a predrill, a bone tamp, a cutter and a forceps. One surgical method of repairing toe deformities includes resecting a proximal interphalangeal joint, drilling a hole in a proximal phalanx using a proximal portion of a pin, removing the pin from the proximal phalanx, drilling a tip of a toe through middle and distal phalanxes, driving the pin retrograde and traversing the distal, middle and proximal phalanxes until the pin stops advancing due to resistance at a proximal cortex, holding the pin and powering a pin driver to separate a distal portion of the pin, and suturing the wound.
    Type: Application
    Filed: October 4, 2007
    Publication date: April 10, 2008
    Inventors: Gerard Bourke, Mihaela Morar, Peter Denove